Evidence map›Paper›PMID 25367881›Full record

ArticleMolecular neurobiology2015

Corilagin Protects Against HSV1 Encephalitis Through Inhibiting the TLR2 Signaling Pathways In Vivo and In Vitro.

Yuan-Jin Guo, Tao Luo, Fei Wu, Huan Liu, Hua-Rong Li, Yuan-Wu Mei, Shu-Ling Zhang, Jun-Yan Tao, Ji-Hua Dong, Yuan Fang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Phytochemicals ofFrontiers in molecular biosciences · 2021
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Yuan-Jin GuoDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Tao LuoDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Fei WuDepartment of Neurology, Wuhan General Hospital of Guangzhou Military Command, Wuhan, 430070, People's Republic of China.
Huan LiuDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Hua-Rong LiDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Yuan-Wu MeiDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Shu-Ling ZhangDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Jun-Yan TaoSchool of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, People's Republic of China.
Ji-Hua DongCentral Lab, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Yuan FangDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Lei ZhaoDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China. leizhao@hust.edu.cn.
Huazhong University of Science and Technology · CNUnion Hospital · CNGeneral Hospital of Guangzhou Military Command · CNHubei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we tried to explore the molecular mechanism that Corilagin protected against herpes simplex virus-1 encephalitis through inhibiting the TLR2 signaling pathways in vivo and in vitro. As a result, Corilagin significantly prevented increase in the levels of TLR2 and its downstream mediators following Malp2 or HSV-1 challenge. On the other hand, in spite of TLR2 knockdown, Corilagin could still significantly suppress the expression of P38 and NEMO, phosphor-P38, and nuclear factor kappa B. The mRNA and protein expression of TLR2 and its downstream mediators in the brain tissue were also significantly lowered in mice treated with Corilagin. In addition, Corilagin inhibited expression of tumor necrosis factor-α (TNF-α) and interleukin (IL)-6 protein. In conclusion, Corilagin shows the potential to protect against HSV-1-induced encephalitis, and the beneficial effects may be mediated by inhibiting TLR2 signaling pathways.

Indexed as

Herpesvirus 1, HumanAnimalsAntiviral AgentsBrainCells, CulturedDown-RegulationEncephalitis, Herpes SimplexGlucosidesHydrolyzable TanninsInterleukin-6Intracellular Signaling Peptides and ProteinsLipopeptidesMaleMembrane GlycoproteinsMiceMice, Inbred BALB CAntiviral AgentscorilaginGlucosidesHydrolyzable TanninsInterleukin-6interleukin-6, mouseIntracellular Signaling Peptides and ProteinsLipopeptidesmacrophage stimulatory lipopeptide 2Membrane GlycoproteinsMyd88 protein, mouseMyeloid Differentiation Factor 88NEMO protein, mouseNerve Tissue ProteinsNF-kappa Bp38 Mitogen-Activated Protein KinasesReceptors, Interleukin-1RNA, MessengerRNA, Small InterferingTIRAP protein, mouseTlr2 protein, mouseTNF Receptor-Associated Factor 6Toll-Like Receptor 2Tumor Necrosis Factor-alphaCorilaginHerpes simplex virus-1InflammationSignaling pathwaysToll-like receptor 2

Identifiers

PMID25367881
OpenAlexW2075321035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.